Medical Device Comparisons (2026)
40 head-to-head matchups. Pricing, clinical evidence, safety data, and a verdict for each.
Last updated: 2026-04-10
When you are evaluating a $50,000 to $250,000 capital equipment purchase, the manufacturer sales rep is not going to give you an honest comparison against their competitor. They will show you their best clinical study and list-price for the competitor, and skip over the adverse event data entirely. Independent, head-to-head comparisons are the only place you can see the full picture before committing capital.
Device Pulse publishes direct comparisons across every category we track. Every matchup below covers ten dimensions: mechanism of action, new pricing, used and refurbished pricing, per-session revenue potential, total cost of ownership, clinical evidence quality, FDA clearance pathway, MAUDE adverse event history, treatment time and patient experience, and practice type fit. We do not accept manufacturer sponsorship for these comparisons. Sources are cited.
Use the comparisons to pressure-test vendor claims, validate your shortlist, or settle an internal disagreement about which platform to buy. Every page ends with a scenario-based verdict that says which device fits which type of practice. A device that is the best choice for a high-volume med spa is not always the right choice for a dermatology practice that prioritizes clinical outcomes over throughput, and our comparisons make that distinction explicit.
How we compare medical devices
Our comparison methodology is consistent across every matchup. We evaluate the ten dimensions listed above, weighted by what matters most for that category. For body contouring, clinical evidence and per-session revenue carry the most weight. For TMS systems, FDA clearance breadth and insurance reimbursement history matter most. For point-of-care ultrasound, image quality and probe versatility dominate. For RF microneedling, needle insulation and depth control shape the comparison. The weighting reflects what physicians care about when writing the check, not what manufacturers want to emphasize in their sales decks.
We do not assign numerical scores or star ratings. Star ratings imply a precision that does not exist in medical device evaluation. They collapse multiple dimensions into a single number that hides the tradeoffs between devices, and they invite manipulation (how do you score "ease of use" on a 10-point scale and defend it?). Instead, we present the raw data and enough context for a physician to make the right decision for their specific practice. A well-informed physician reading our comparison should be able to reach their own verdict, which is the whole point.
Pricing data comes from authorized dealers, DOTmed secondary market listings, and direct practice surveys. New pricing reflects typical transaction prices, not list prices. Used pricing reflects recent secondary market sales, updated monthly. Clinical evidence comes from PubMed-indexed peer-reviewed publications, with manufacturer-funded studies flagged separately so you know which data is independent. Safety data comes directly from the FDA MAUDE database, which we monitor continuously for every tracked device. We look at raw report counts, trend direction, severity classification, and the ratio of reports to installed base. Financial data on publicly traded manufacturers comes from SEC filings.
Every comparison page ends with a scenario-based verdict section, not a winner declaration. We explain which device fits which type of practice, which patient mix, and which practice economics. A high-volume urban med spa and a suburban dermatology clinic should rarely buy the same platform, and our comparisons make that distinction explicit rather than pretending one device is universally superior.